213 related articles for article (PubMed ID: 24046360)
1. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
Carofino BL; Ayanga B; Justice MJ
Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
[TBL] [Abstract][Full Text] [Related]
2. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
[TBL] [Abstract][Full Text] [Related]
3. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.
Carofino BL; Ayanga B; Tracey LJ; Brooke-Bisschop T; Justice MJ
Biol Open; 2016 May; 5(5):645-53. PubMed ID: 27106930
[TBL] [Abstract][Full Text] [Related]
4. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
Dettman EJ; Simko SJ; Ayanga B; Carofino BL; Margolin JF; Morse HC; Justice MJ
Oncogene; 2011 Jun; 30(25):2859-73. PubMed ID: 21339739
[TBL] [Abstract][Full Text] [Related]
5. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
6. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
7. PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation.
Okashita N; Sakashita N; Ito K; Mitsuya A; Suwa Y; Seki Y
Biochem Biophys Res Commun; 2015 Oct; 466(1):138-45. PubMed ID: 26325469
[TBL] [Abstract][Full Text] [Related]
8. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
9. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.
Rakowski LA; Garagiola DD; Li CM; Decker M; Caruso S; Jones M; Kuick R; Cierpicki T; Maillard I; Chiang MY
Cancer Res; 2013 Jan; 73(2):930-41. PubMed ID: 23161489
[TBL] [Abstract][Full Text] [Related]
10. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
11. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
[TBL] [Abstract][Full Text] [Related]
12. A critical role of PRDM14 in human primordial germ cell fate revealed by inducible degrons.
Sybirna A; Tang WWC; Pierson Smela M; Dietmann S; Gruhn WH; Brosh R; Surani MA
Nat Commun; 2020 Mar; 11(1):1282. PubMed ID: 32152282
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
14. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
15. [Effect of PDK1 on Notch1-Induced Mouse T-cell Acute Lymphoblastic Leukemia].
Wang L; Hu TY; Chen X; Li C; Guo HD; Chu YJ; Wang XM; Wang WL; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):637-42. PubMed ID: 27342483
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
Ji J; Cao J; Chen P; Huang R; Ye SD
J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
[TBL] [Abstract][Full Text] [Related]
17. PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia.
Govaerts I; Prieto C; Vandersmissen C; Gielen O; Jacobs K; Provost S; Nittner D; Maertens J; Boeckx N; De Keersmaecker K; Segers H; Cools J
J Hematol Oncol; 2021 Jun; 14(1):97. PubMed ID: 34167562
[TBL] [Abstract][Full Text] [Related]
18. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.
Volanakis EJ; Williams RT; Sherr CJ
Blood; 2009 Nov; 114(20):4451-9. PubMed ID: 19759355
[TBL] [Abstract][Full Text] [Related]
20. ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation.
Nady N; Gupta A; Ma Z; Swigut T; Koide A; Koide S; Wysocka J
Elife; 2015 Nov; 4():e10150. PubMed ID: 26523391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]